Tinnitus
183 results
49 - 148
Ginkgo biloba for tinnitus
Antidepressants for treatment of tinnitus - Cognitive behavioural therapy for tinnitus
- Anticonvulsants for tinnitus: Cochrane systematic review
- Repetitive transcranial magnetic stimulation for tinnitus
- Cognitive behavioural therapy for tinnitus: Cochrane systematic review
- Cognitive behavioural therapy for tinnitus
- Antidepressants for patients with tinnitus: Cochrane systematic review
- Gingko biloba and other alternative treatments for tinnitus
- Repetitive transcranial magnetic stimulation for tinnitus: Cochrane systematic review
Herbal combination might be effective for nonpulsatile tinnitus- Betahistine is ineffective for the treatment of primary tinnitus
- Sound therapy (using amplification devices and/or sound generators) for tinnitus
- Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus
- Sound therapy (masking) in the management of tinnitus in adults: Cochrane systematic review
- Sound masking, cognitive behavior therapy, and patient education may help tinnitus symptoms
- Amplification with hearing aids for patients with tinnitus and co‐existing hearing loss
- Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus
- Tinnitus guidelines from the United Kingdom's National Institute for Health and Care Excellence (NICE)
- Sound therapy (masking or using amplification devices and/or sound generators) in the management of tinnitus
- Acute acoustic trauma
- Otosclerosis
- Betahistine for Ménière's disease or syndrome
- Vasculitides
- Diuretics for Ménière's disease or syndrome
- Acute mastoiditis
- Acute otitis media in adults
- Platinum‐induced hearing loss after treatment for childhood cancer
- Vertigo
- Ménière's disease
- Benign paroxysmal positional vertigo (BPPV)
- aDrugs commonly causing poisonings
- Surgery for Ménière's disease
- Clinical neurophysiology in diagnostics
- Different infusion durations for preventing platinum‐induced hearing loss in children with cancer
- Intratympanic steroids for Ménière's disease or syndrome: Cochrane systematic review
- Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome
- Positive pressure therapy for Ménière's disease or syndrome
- Intratympanic gentamicin for Ménière's disease or syndrome
- Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis): Cochrane systematic review
- Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss: Cochrane systematic review
- Steroids for idiopathic sudden sensorineural hearing loss
- Giant cell (temporal) arteritis
- Idiopathic sudden sensorineural hearing loss
- Surgery for Ménière's disease
- Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults
- Transcranial magnetic stimulation for the treatment of epilepsy
- Repetitive transcranial magnetic stimulation for improving function after stroke
- Antivirals for idiopathic sudden sensorineural hearing loss: Cochrane systematic review
- Long-term benzodiazepine use and withdrawal
- Lifestyle and dietary interventions for Ménière’s disease
- Positive pressure therapy for Ménière’s disease
- Surgical interventions for Ménière’s disease
- Systemic pharmacological interventions for Ménière’s disease
- Hyperbaric oxygen therapy (HBOT)
- Intratympanic gentamicin for Ménière’s disease
- Surgical interventions for the early management of Bell's palsy
- Continuous infusion or intermittent bolus administration of loop diuretics in acutely decompensated heart failure